Sera Prognostics at TD Cowen Conference: Strategic Moves in Preterm Birth Prediction

On Monday, 02 March 2026, Sera Prognostics (NASDAQ:SERA) presented its strategic initiatives at the TD Cowen 46th Annual Health Care Conference. The company focused on addressing the unmet need for preterm birth prediction and shared its plans for commercialization following the PRIME study. While the company is optimistic about expanding into Europe, challenges remain in navigating the fragmented healthcare reimbursement landscape in the United States.